Blunted metabolic response to SKF 82958 in the mesolimbic system following preweaning cocaine treatment

Developmental Brain Research

Volumn 143, Issue 2, 2003, Pages 253-259

  Melnick, Susan M ^a   Dow Edwards, Diana L ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

D1 receptor; Drug abuse; Glucose metabolism; Prenatal cocaine; Rat; SKF 82958

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; GLUCOSE; WATER;

ADULTHOOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE METABOLISM; LIMBIC SYSTEM; MALE; METABOLIC RATE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROVOCATION TEST; RAT; WEANING;

EID: 0038500743     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(03)00098-1     Document Type: Article

References (35)

1. 1 receptor efficacy. Eur. J. Pharmacol. 188:1990;335-347.
2. Bayer S.A., Altman J., Russo R.J., Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology. 14:1993;83-144.
3. Busidan Y., Dow-Edwards D.L. Behavioral sensitization to apomorphine in adult rats exposed to cocaine during the preweanling period: A preliminary study. Pharmacol. Biochem. Behav. 63:1999;417-421.
4. Choi S.J., Mazzio E., Kolta M.G., Soliman K.F. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain. Ann. NY Acad. Sci. 844:1998;293-302.
5. 2 dopamine agonists affects glucose utilization in both the direct and indirect pathways of the rat basal ganglia. Neurosci. Lett. 309:2001;161-164.
6. Dow-Edwards D., Busidan Y. Behavioral responses to dopamine agonists in adult rats exposed to cocaine during the preweaning period. Pharmacol. Biochem. Behav. 70:2001;23-30.
7. Dow-Edwards D., Mayes L., Spear L., Hurd Y. Cocaine and development: Clinical, behavioral and neurobiological perspectives. Neurotoxicol. Teratol. 21:1999;481-490.
8. Dow-Edwards D.L., Freed-Malen L.A., Hughes H.E. Long-term alterations in brain function following cocaine administration during the preweanling period. Dev. Brain Res. 72:1993;309-313.
9. Dow-Edwards D.L., Hurd Y.L. Perinatal cocaine decreases the expression of prodynorphin mRNA in nucleus accumbens shell in the adult rat. Mol. Brain Res. 62:1998;82-85.
10. 2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Neuroscience. 54:1993;1051-1061.
11. Frick G.S., Dow-Edwards D.L. The roles of serotonergic and dopaminergic reuptake blockade in producing cocaine's effects on cerebral function in periweanling rats. Dev. Brain Res. 88:1995;158-170.
12. Friedman E., Yadin E., Wang H.-Y. Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience. 70:1996;739-747.
13. 2 dopamine receptor interaction in membrane abolished by 6-hydroxydopamine lesion. Life Sci. 63:1998;PL7-12.
14. 1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: An effect blocked by N-methyl-D-aspartate antagonists. J. Pharmacol. Exp. Ther. 260:1992;409-416.
15. 2 receptors in the nucleus accumbens in mediating reward. J. Neurosci. 17:1997;8580-8587.
16. 1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J. Neurosci. 20:2000;4606-4614.
17. 4 receptors in the striatum without the involvement of action potentials. J. Neurosci. 20:2000;6666-6671.
18. Melnick S.M., Dow-Edwards D.L. Differential behavioral responses to chronic amphetamine in adult male and female rats exposed to postnatal cocaine treatment. Pharmacol. Biochem. Behav. 69:2001;219-224.
19. S.M. Melnick, D.L. Dow-Edwards, Correlating brain metabolism with stereotypic and locomotor behavior, Behav. Res. Methods Instrum. Comput., (in press).
20. Moody C.A., Frambes N.A., Spear L.P. Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine. Psychopharmacology. 108:1992;256-262.
21. 2 dopamine receptor interaction: An in vivo single unit electrophysiological study. Neuroreport. 8:1997;783-787.
22. 1, modify brain glucose metabolism. Brain Res. 327:1985;390-394.
23. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
24. Porrino L.J., Lucignani G., Dow-Edwards D., Sokoloff L. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res. 307:1984;311-320.
25. 2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA). J. Neurochem. 77:2001;1248-1255.
26. 2 dopamine binding associated with an increase in ligand binding affinity. Pharmacol. Biochem. Behav. 37:1990;371-373.
27. 2 interaction in feedback control of midbrain dopamine neurons. J. Neurosci. 17:1997;7988-7994.
28. Shi X., Yin R., Dow-Edwards D. Chronic haloperidol alters dopamine receptors: Effects of cocaine exposure during the preweanling period. Eur. J. Pharmacol. 370:1999;241-249.
29. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:1977;897-916.
30. Stewart C.W., Scalzo F.M., Valentine J., Holson R.R., Ali S.F., Slikker W. Gestational exposure to cocaine or pharmacologically related compounds: Effects on behavior and striatal dopamine receptors. Life Sci. 63:1998;2015-2022.
31. Sun B.C., Huang K.X., Jin G.Z. Repeated reserpine treatment alters firing pattern and responses of substantia nigral dopamine neurons. Eur. J. Pharmacol. 231:1993;331-338.
32. 1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation. Brain Res. 607:1993;270-274.
33. 2 interaction. Waddington J.L. D1:D2 Dopamine Receptor Interactions. 1993;52-78 Academic Press, San Diego, CA.
34. 1 dopamine receptor-mediated activation of striatal Gs proteins. J. Pharmacol. Exp. Ther. 273:1995;492-498.
35. 1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex. J. Neurosci. 21:2001;9160-9167.